Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC).
Moutafi MK, Bates KM, Aung TN, Milian RG, Xirou V, Vathiotis IA, Gavrielatou N, Angelakis A, Schalper KA, Salichos L, Rimm DL. Moutafi MK, et al. Among authors: gavrielatou n. J Immunother Cancer. 2024 Jun 10;12(6):e009039. doi: 10.1136/jitc-2024-009039. J Immunother Cancer. 2024. PMID: 38857914 Free PMC article.
Spatially informed gene signatures for response to immunotherapy in melanoma.
Aung TN, Warrell J, Martinez-Morilla S, Gavrielatou N, Vathiotis I, Yaghoobi V, Kluger HM, Gerstein M, Rimm DL. Aung TN, et al. Among authors: gavrielatou n. Clin Cancer Res. 2024 Jun 5. doi: 10.1158/1078-0432.CCR-23-3932. Online ahead of print. Clin Cancer Res. 2024. PMID: 38837895
Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms.
Kyriazoglou A, Pagkali A, Kotsantis I, Economopoulou P, Kyrkasiadou M, Moutafi M, Gavrielatou N, Anastasiou M, Boulouta A, Pantazopoulos A, Giannakakou M, Digklia A, Psyrri A. Kyriazoglou A, et al. Among authors: gavrielatou n. Cancer Treat Rev. 2024 Apr;125:102716. doi: 10.1016/j.ctrv.2024.102716. Epub 2024 Mar 11. Cancer Treat Rev. 2024. PMID: 38492514 Review.
Immune checkpoint inhibitors in sarcomas: a systematic review.
Anastasiou M, Kyriazoglou A, Kotsantis I, Economopoulou P, Kyrkasiadou M, Giannopoulou A, Kosmidou A, Smerdi D, Moutafi M, Gavrielatou N, Psyrri A. Anastasiou M, et al. Among authors: gavrielatou n. Immunooncol Technol. 2023 Sep 28;20:100407. doi: 10.1016/j.iotech.2023.100407. eCollection 2023 Dec. Immunooncol Technol. 2023. PMID: 38192615 Free PMC article. Review.
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma.
Gavrielatou N, Fortis E, Spathis A, Anastasiou M, Economopoulou P, Foukas GRP, Lelegiannis IM, Rusakiewicz S, Vathiotis I, Aung TN, Tissot S, Kastrinou A, Kotsantis I, Vagia EM, Panayiotides I, Rimm DL, Coukos G, Homicsko K, Foukas P, Psyrri A. Gavrielatou N, et al. Ann Oncol. 2024 Apr;35(4):340-350. doi: 10.1016/j.annonc.2023.12.011. Epub 2023 Dec 28. Ann Oncol. 2024. PMID: 38159908 Free article. Clinical Trial.
Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond.
Lozar T, Laklouk I, Golfinos AE, Gavrielatou N, Xu J, Flynn C, Keske A, Yu M, Bruce JY, Wang W, Grasic Kuhar C, Bailey HH, Harari PM, Dinh HQ, Rimm DL, Hu R, Lambert PF, Fitzpatrick MB. Lozar T, et al. Among authors: gavrielatou n. Cancers (Basel). 2023 Oct 9;15(19):4905. doi: 10.3390/cancers15194905. Cancers (Basel). 2023. PMID: 37835599 Free PMC article.
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.
Moutafi M, Koliou GA, Papaxoinis G, Economopoulou P, Kotsantis I, Gkotzamanidou M, Anastasiou M, Pectasides D, Kyrodimos E, Delides A, Giotakis E, Papadimitriou NG, Panayiotides IG, Perisanidis C, Fernandez AI, Xirou V, Poulios C, Gagari E, Yaghoobi V, Gavrielatou N, Shafi S, Aung TN, Kougioumtzopoulou A, Kouloulias V, Palialexis K, Gkolfinopoulos S, Strati A, Lianidou E, Fountzilas G, Rimm DL, Foukas PG, Psyrri A. Moutafi M, et al. Among authors: gavrielatou n. Cancer Res Commun. 2023 Aug 10;3(8):1514-1523. doi: 10.1158/2767-9764.CRC-23-0051. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37575280 Free PMC article. Clinical Trial.
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma.
Gavrielatou N, Vathiotis I, Aung TN, Shafi S, Burela S, Fernandez AI, Moutafi M, Burtness B, Economopoulou P, Anastasiou M, Foukas P, Psyrri A, Rimm DL. Gavrielatou N, et al. Cancer Res Commun. 2023 Apr 11;3(4):558-563. doi: 10.1158/2767-9764.CRC-22-0299. eCollection 2023 Apr. Cancer Res Commun. 2023. PMID: 37057033 Free PMC article.
Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.
Aung TN, Gavrielatou N, Vathiotis IA, Fernandez AI, Shafi S, Yaghoobi V, Burela S, MacNeil T, Ahmed FS, Myint H, Flies DB, Langermann S, Rimm DL. Aung TN, et al. Among authors: gavrielatou n. Cancer Res Commun. 2023 Mar 21;3(3):471-482. doi: 10.1158/2767-9764.CRC-22-0334. eCollection 2023 Mar. Cancer Res Commun. 2023. PMID: 36960400 Free PMC article.
30 results